Magnus Ekström

TL;DR: Lower dose opioids are not associated with increased admissions or deaths in patients with COPD and might be safe for symptom reduction in severe respiratory disease.

TL;DR: One-third of asthma patients in Sweden were SABA overusers (three or more canisters per year), of whom 28% had no collection of anti-inflammatory drugs, and monitoring of SABA usage should be key in improving asthma management.

TL;DR: Criteria for chronic breathlessness syndrome is proposed and an important first step to address the therapeutic nihilism that has pervaded this neglected symptom and could empower patients and caregivers, improve clinical care, focus research, and encourage wider uptake of available and emerging evidence-based interventions.

TL;DR: Opioids improved breathlessness but not exercise capacity in severe COPD, and the quality of evidence was moderate for systemic opioids and low for nebulized opioids on breathlessness.

TL;DR: This study supports that antiplatelet drugs improve survival and β-blockers decrease survival in oxygen-dependent COPD.